Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.

Han X, Chiang C, Leonard CE, Bilker WB, Brensinger CM, Li L, Hennessy S.

Epidemiology. 2017 May;28(3):459-468. doi: 10.1097/EDE.0000000000000638.

PMID:
28169935
2.

Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.

Rhee CM, Kovesdy CP, Kalantar-Zadeh K.

Nephron. 2017;135(2):147-153. doi: 10.1159/000450862. Epub 2016 Oct 20.

PMID:
27760420
4.

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).

Kanatsuka A, Sato Y, Kawai K, Hirao K, Kobayashi M, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group (JDDM), Abe N, Arai K, Fujiya H, Fukumoto Y, Dake F, Iizumi T, Ito M, Iwasaki K, Kanamori A, Kato S, Kato M, Kawara A, Kimura K, Chikamori K, Iemitsu K, Kou S, Kudo M, Kurihara Y, Lee G, Tsuruoka A, Manda N, Matoba K, Hayashi H, Minami M, Kuribayashi N, Miyazawa K, Chiba Y, Osonoi T, Nakamura S, Sasaki H, Komori K, Oishi M, Okada A, Okuguchi F, Yanagisawa M, Sugimoto H, Sugiyama H, Takai M, Takaki M, Takamura H, Takeda H, Takeda H, Tanaka K, Miwa T, Tomonaga O, Taguchi M, Yamazaki K, Wada T, Yagi N, Yamaoka K, Yuhara A.

J Diabetes Investig. 2016 May;7(3):386-95. doi: 10.1111/jdi.12430. Epub 2015 Nov 12.

5.

Management of Type 2 Diabetes in the Setting of Morbid Obesity: How Can Weight Gain Be Prevented or Reversed?

Lahiri SW.

Clin Diabetes. 2016 Apr;34(2):115-20. doi: 10.2337/diaclin.34.2.115. No abstract available.

6.

Double-diabetes in a real-world sample of 2711 individuals: associated with insulin treatment or part of the heterogeneity of type 1 diabetes?

Giuffrida FM, Bulcão C, Cobas RA, Negrato CA, Gomes MB, Dib SA; Brazilian Type 1 Diabetes Study Group (BrazDiab1SG).

Diabetol Metab Syndr. 2016 Mar 22;8:28. doi: 10.1186/s13098-016-0143-7. eCollection 2016.

7.

Metformin versus insulin for gestational diabetes mellitus: a meta-analysis.

Zhao LP, Sheng XY, Zhou S, Yang T, Ma LY, Zhou Y, Cui YM.

Br J Clin Pharmacol. 2015 Nov;80(5):1224-34. doi: 10.1111/bcp.12672. Epub 2015 Jul 14. Review.

8.

Simplicity, safety, and acceptability of insulin pen use versus the conventional vial/syringe device in patients with type 1 and type 2 diabetes mellitus in Lebanon.

Ramadan WH, Khreis NA, Kabbara WK.

Patient Prefer Adherence. 2015 Mar 27;9:517-28. doi: 10.2147/PPA.S78225. eCollection 2015.

10.

Pancreas transplantation in type II diabetes mellitus.

Weems P, Cooper M.

World J Transplant. 2014 Dec 24;4(4):216-21. doi: 10.5500/wjt.v4.i4.216. Review.

11.

Dapagliflozin efficacy and safety: a perspective review.

Anderson SL.

Ther Adv Drug Saf. 2014 Dec;5(6):242-54. doi: 10.1177/2042098614551938. Review.

12.

Metformin in cancer prevention and therapy.

Kasznicki J, Sliwinska A, Drzewoski J.

Ann Transl Med. 2014 Jun;2(6):57. doi: 10.3978/j.issn.2305-5839.2014.06.01. Review.

13.

Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis.

Hemmingsen B, Schroll JB, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.

CMAJ Open. 2014 Jul 22;2(3):E162-75. doi: 10.9778/cmajo.20130073. eCollection 2014 Jul.

14.

An automated telephone nutrition support system for Spanish-speaking patients with diabetes.

Khanna R, Stoddard PJ, Gonzales EN, Villagran-Flores M, Thomson J, Bayard P, Palos Lucio AG, Schillinger D, Bertozzi S, Gonzales R.

J Diabetes Sci Technol. 2014 Nov;8(6):1115-20. doi: 10.1177/1932296814550186. Epub 2014 Sep 19.

15.

Treating the elderly diabetic patient: special considerations.

Kezerle L, Shalev L, Barski L.

Diabetes Metab Syndr Obes. 2014 Aug 28;7:391-400. doi: 10.2147/DMSO.S48898. eCollection 2014. Review.

16.

Glycemic control: a combination of lifestyle management and the use of drugs.

Standl E, Erbach M, Schnell O.

Cardiol Ther. 2013 Jun;2(1):1-16. doi: 10.1007/s40119-012-0007-7. Epub 2012 Nov 27.

17.

Patient considerations in the management of type 2 diabetes - critical appraisal of dapagliflozin.

Salvo MC, Brooks AD, Thacker SM.

Patient Prefer Adherence. 2014 Apr 22;8:493-502. doi: 10.2147/PPA.S59169. eCollection 2014. Review.

18.

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

Solomon DH, Bitton A, Katz JN, Radner H, Brown EM, Fraenkel L.

Arthritis Rheumatol. 2014 Apr;66(4):775-82. doi: 10.1002/art.38323. Review. No abstract available.

19.

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.

Zhou K, Donnelly L, Yang J, Li M, Deshmukh H, Van Zuydam N, Ahlqvist E; Wellcome Trust Case Control Consortium 2, Spencer CC, Groop L, Morris AD, Colhoun HM, Sham PC, McCarthy MI, Palmer CN, Pearson ER.

Lancet Diabetes Endocrinol. 2014 Jun;2(6):481-7. doi: 10.1016/S2213-8587(14)70050-6. Epub 2014 Mar 19.

20.

Renal endothelial dysfunction in diabetic nephropathy.

Cheng H, Harris RC.

Cardiovasc Hematol Disord Drug Targets. 2014;14(1):22-33. Review.

Supplemental Content

Support Center